Disclosure Panels Details Page
Bladder/Penile Cancers Panel - Disclosures as of 04/24/2024
|
Panel Member
(Spouse/Domestic Partner/Dependent) |
Clinical Research Support/Data Safety Monitoring Board | Scientific Advisory Boards, Consultant, or Expert Witness | Promotional Advisory Boards, Consultant, or Speakers Bureau | Employment/ Governing Board, Patent, Equity, or Royalty | Has Attended |
|---|---|---|---|---|---|
| Michael Abern MD | Medtronic, Inc. | None | None | None | - |
| Neeraj Agarwal MD | None | None | None | None | - |
| Rick Bangs MBA, PMP | None | Gilead Sciences, Inc. Nonagen |
None | Gilead Sciences, Inc.|Nonagen | - |
| Marian Birkeland PhD | None | None | None | None | - |
| Nicole Blankenhorn | None | None | None | None | - |
| Mark Buyyounouski MD, MS, FASTRO | None | None | None | None | - |
| Carly Cassara MSc | None | None | None | None | - |
| Kevin Chan MD | None | None | None | None | - |
| Paul Chang MD | None | None | None | None | - |
| Sam Chang MD, MBA | Astellas Pharma US, Inc. folde ImmunityBio Inc Janssen Pharmaceutica Products, LP Lantheus Merck & Co., Inc. Nonagen pacific edge Pfizer Inc. photocure inc. Prokarium Tu Therapeutics urogen inc Valar Labs Vesica Health |
Astellas Pharma US, Inc. CG Oncology Expert witness testimony folde Janssen Pharmaceutica Products, LP Lantheus Merck & Co., Inc. mIR Nonagen Pacific Edge photocure Prokarium Tu Therapeutics Urogen Valar Labs Vesica Health |
None | None | - |
| Sarah DeVincenzo PharmD, BCPS | None | None | None | None | - |
| Thomas Flaig MD | Agensys, Inc. Astellas Pharma US, Inc. AstraZeneca Pharmaceuticals LP Bristol Myers Squibb Criterium Genentech, Inc. Janssen Pharmaceutica Products, LP Merck & Co., Inc. Myovant sanofi-aventis U.S. SeaGen |
Aurora Oncology Janssen Pharmaceutica Products, LP |
None | Aurora Oncology - this is a faculty start up. No marketed products or products in clinical trials. |Joint Venture - University of Colorado and UCHealth |The University of Colorado was issued patents for work I did as a university employee in my laboratory - two patents have now been issued for this work and licensed to Aurora Oncology. There are no commercial products related to this work. | - |
| Terence Friedlander MD | AstraZeneca Pharmaceuticals LP Genentech, Inc. SeaGen Tizona/Trishula Pharmaceuticals |
AbbVie, Inc. Astellas Pharma US, Inc. Bicycle Therapeutics Gilead Sciences, Inc. Merck & Co., Inc. SeaGen |
None | None | - |
| Kristina Gregory MSN, RN | None | None | None | None | - |
| Lisa Gurski PhD | None | None | None | None | - |
| Khurshid Guru MD | None | None | None | None | - |
| Evelyn Handel PharmD, BCOP, BCPS | None | None | None | None | - |
| Harry Herr MD | None | None | None | None | - |
| Erin Hesler | None | None | None | None | - |
| Jean Hoffman-Censits MD | Astellas Pharma US, Inc. Daiichi- Sankyo Co. EMD Serono Genentech, Inc. Ikena SeaGen |
Gilead Sciences, Inc. | None | None | - |
| Hristos Kaimakliotis MD | None | Early is good Urogen |
None | None | - |
| Amar Kishan MD | Janssen Pharmaceutica Products, LP Point Biopharma |
Boston Scientific Corporation Janssen Pharmaceutica Products, LP Lantheus Varian Medical Systems, Inc. |
None | None | - |
| Shilajit Kundu MD | None | None | None | None | - |
| Subodh Lele MD | None | None | None | None | - |
| Ronac Mamtani MD, MSCE | Astellas Pharma US, Inc. Bristol Myers Squibb LOXO Merck & Co., Inc. |
Aaronson Rappaport Feinstein & Deutsch, LLP Aptitude Health Astellas Pharma US, Inc. Bristol Myers Squibb Curio Science SeaGen The Perry Law Firm, LLC |
None | None | - |
| Omar Mian MD, PhD | None | Bayer HealthCare | None | None | - |
| Jeff Michalski MD, MBA | None | None | None | None | - |
| Jeffrey Montgomery MD, MHSA | None | None | None | None | - |
| John Murphy | None | None | None | None | - |
| Mamta Parikh MD, MS | Gilead Sciences, Inc. Karyopharm Therapeutics |
Pfizer Inc. sanofi-aventis U.S. |
None | None | - |
| Anthony Patterson MD | None | None | None | None | - |
| Charles Peyton MD | ECOG Janssen Pharmaceutica Products, LP |
expert witness consultation | None | None | - |
| Elizabeth Plimack MD, MS | Bristol Myers Squibb Merck & Co., Inc. Pfizer Inc. |
AbbVie, Inc. Astellas Pharma US, Inc. AstraZeneca Pharmaceuticals LP Eisai Inc. EMD Serono Merck & Co., Inc. Pfizer Inc. SeaGen Synthekine |
None | None | - |
| Donna Powell DHSc, CMD, RT(T) | None | None | None | None | - |
| Mark Preston MD, MPH | Merck & Co., Inc. | Bayer HealthCare Janssen Pharmaceutica Products, LP Pfizer Inc. |
None | None | - |
| Kyle Richards MD, FACS | None | None | None | None | - |
| Arlene Siefker-Radtke MD | Basilea Bristol Myers Squibb Gilead Sciences, Inc. Janssen Pharmaceutica Products, LP Loxo Merck & Co., Inc. Nektar Therapeutics |
Astellas Pharma US, Inc. G1 Therapeutics Ideeya Immunomedics, Inc. Janssen Pharmaceutica Products, LP Loxo Merck & Co., Inc. SeaGen |
None | None | - |
| Philippe Spiess MD, MS, FACS, FRCS | None | None | None | None | - |
| Tyler Stewart MD | GRAIL | Astellas Pharma US, Inc. AstraZeneca Pharmaceuticals LP SeaGen |
None | None | - |
| Bettyanne Sunderland BSN, OCN | None | None | None | None | - |
| Debasish Sundi MD | Apalutamide NMIBC clinical trial (NCI DCP) Department of Defense sponsored biomarker research Doris Duke Charitable Foundation - translational research grant |
None | None | None | - |
| Matthew Tollefson MD | None | None | None | None | - |
| Jonathan Tward MD, PhD | Bayer HealthCare Myriad Genetic Laboratories, Inc. |
Myriad Genetic Laboratories, Inc. | None | None | - |
| Jonathan Wright MD, MS, FACS | Bristol Myers Squibb Janssen Pharmaceutica Products, LP Merck & Co., Inc. Pacific Edge SeaGen Veracyte |
ImmunityBio pacific edge |
None | UpToDate | - |